These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 29764346)

  • 1. Identifying genes in Parkinson disease: state of the art.
    Chew EG; Foo JN; Tan EK
    Med J Aust; 2018 May; 208(9):381-382. PubMed ID: 29764346
    [No Abstract]   [Full Text] [Related]  

  • 2. Genetic analysis of pathways to Parkinson disease.
    Hardy J
    Neuron; 2010 Oct; 68(2):201-6. PubMed ID: 20955928
    [TBL] [Abstract][Full Text] [Related]  

  • 3. From GWAS to clinical utility in Parkinson's disease.
    Klein C; Ziegler A
    Lancet; 2011 Feb; 377(9766):613-4. PubMed ID: 21292316
    [No Abstract]   [Full Text] [Related]  

  • 4. Lysosomal Storage Disorders Shed Light on Lysosomal Dysfunction in Parkinson's Disease.
    Blumenreich S; Barav OB; Jenkins BJ; Futerman AH
    Int J Mol Sci; 2020 Jul; 21(14):. PubMed ID: 32674335
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of SNCA with Parkinson: replication in the Harvard NeuroDiscovery Center Biomarker Study.
    Ding H; Sarokhan AK; Roderick SS; Bakshi R; Maher NE; Ashourian P; Kan CG; Chang S; Santarlasci A; Swords KE; Ravina BM; Hayes MT; Sohur US; Wills AM; Flaherty AW; Unni VK; Hung AY; Selkoe DJ; Schwarzschild MA; Schlossmacher MG; Sudarsky LR; Growdon JH; Ivinson AJ; Hyman BT; Scherzer CR
    Mov Disord; 2011 Oct; 26(12):2283-6. PubMed ID: 21953863
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Using whole-exome sequencing to investigate the genetic bases of lysosomal storage diseases of unknown etiology.
    Wang N; Zhang Y; Gedvilaite E; Loh JW; Lin T; Liu X; Liu CG; Kumar D; Donnelly R; Raymond K; Schuchman EH; Sleat DE; Lobel P; Xing J
    Hum Mutat; 2017 Nov; 38(11):1491-1499. PubMed ID: 28703315
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic basis of Parkinson disease.
    Xiromerisiou G; Dardiotis E; Tsimourtou V; Kountra PM; Paterakis KN; Kapsalaki EZ; Fountas KN; Hadjigeorgiou GM
    Neurosurg Focus; 2010 Jan; 28(1):E7. PubMed ID: 20043722
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Absence of SNCA polymorphisms in Pakistani Parkinsons disease patients.
    ; Sultan A; Usmani MA; Ghaffar M; Ali J; Badshah M; Ahmad N
    J Pak Med Assoc; 2017 Oct; 67(10):1512-1516. PubMed ID: 28955066
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An updated analysis with 45,078 subjects confirms the association between SNCA rs11931074 and Parkinson's disease.
    Liu X; Zhu R; Xiao T; Li Q; Zhu Y; He Z
    Neurol Sci; 2018 Dec; 39(12):2061-2069. PubMed ID: 30120622
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SNCA, LRRK2, MAPT polymorphisms and Parkinson's disease in Russia.
    Emelyanov A; Andoskin P; Yakimovskii A; Usenko T; Nuzhnyi E; Nikolaev M; Pchelina S
    Parkinsonism Relat Disord; 2013 Nov; 19(11):1064-5. PubMed ID: 23830801
    [No Abstract]   [Full Text] [Related]  

  • 11. A common polymorphism in
    Stoker TB; Camacho M; Winder-Rhodes S; Liu G; Scherzer CR; Foltynie T; Barker RA; Williams-Gray CH
    J Neurol Neurosurg Psychiatry; 2020 Jun; 91(6):673-674. PubMed ID: 32241921
    [No Abstract]   [Full Text] [Related]  

  • 12. Cyclin-G-associated kinase modifies α-synuclein expression levels and toxicity in Parkinson's disease: results from the GenePD Study.
    Dumitriu A; Pacheco CD; Wilk JB; Strathearn KE; Latourelle JC; Goldwurm S; Pezzoli G; Rochet JC; Lindquist S; Myers RH
    Hum Mol Genet; 2011 Apr; 20(8):1478-87. PubMed ID: 21258085
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Excessive burden of lysosomal storage disorder gene variants in Parkinson's disease.
    Robak LA; Jansen IE; van Rooij J; Uitterlinden AG; Kraaij R; Jankovic J; ; Heutink P; Shulman JM
    Brain; 2017 Dec; 140(12):3191-3203. PubMed ID: 29140481
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Is Parkinson's disease a lysosomal disorder?
    Klein AD; Mazzulli JR
    Brain; 2018 Aug; 141(8):2255-2262. PubMed ID: 29860491
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic convergence of Parkinson's disease and lysosomal storage disorders.
    Deng H; Xiu X; Jankovic J
    Mol Neurobiol; 2015; 51(3):1554-68. PubMed ID: 25099932
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genome-wide association study confirms SNPs in SNCA and the MAPT region as common risk factors for Parkinson disease.
    Edwards TL; Scott WK; Almonte C; Burt A; Powell EH; Beecham GW; Wang L; Züchner S; Konidari I; Wang G; Singer C; Nahab F; Scott B; Stajich JM; Pericak-Vance M; Haines J; Vance JM; Martin ER
    Ann Hum Genet; 2010 Mar; 74(2):97-109. PubMed ID: 20070850
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lysosomal storage disorders and Parkinson's disease: Gaucher disease and beyond.
    Shachar T; Lo Bianco C; Recchia A; Wiessner C; Raas-Rothschild A; Futerman AH
    Mov Disord; 2011 Aug; 26(9):1593-604. PubMed ID: 21618611
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of GWAS-linked loci in Parkinson disease reaffirms PARK16 as a susceptibility locus.
    Tan EK; Kwok HH; Tan LC; Zhao WT; Prakash KM; Au WL; Pavanni R; Ng YY; Satake W; Zhao Y; Toda T; Liu JJ
    Neurology; 2010 Aug; 75(6):508-12. PubMed ID: 20697102
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Variants in GBA, SNCA, and MAPT influence Parkinson disease risk, age at onset, and progression.
    Davis AA; Andruska KM; Benitez BA; Racette BA; Perlmutter JS; Cruchaga C
    Neurobiol Aging; 2016 Jan; 37():209.e1-209.e7. PubMed ID: 26601739
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Gene for sporadic Parkinson's disease: common disease-common variants].
    Toda T; Satake W
    Rinsho Shinkeigaku; 2010 Nov; 50(11):864. PubMed ID: 21921475
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.